Enzychem Lifesciences Corp. (183490) Stock Statistics & Valuation Metrics

Enzychem Lifesciences Corp. has a market cap or net worth of ₩76.86B. The enterprise value is -₩18.22K.

Enzychem Lifesciences Corp. has 84,640,236 shares outstanding. The number of shares has decreased by -2.65% in one year.

Enzychem Lifesciences Corp.’s return on equity (ROE) is -0.13 and return on invested capital (ROIC) is -9.01%.

The current PE Ratio of Enzychem Lifesciences Corp. is ―. Enzychem Lifesciences Corp.’s PEG ratio is 0.43.

In the last 12 months, Enzychem Lifesciences Corp. had revenue of 67.75B and earned -18.13B in profits. Earnings per share was -234.08.

In the last 12 months, operating cash flow was -11.01B and capital expenditures -779.47M, giving a free cash flow of -11.79B billion.

Enzychem Lifesciences Corp. pays an annual dividend of ―, resulting in a dividend yield of ―

Enzychem Lifesciences Corp. upcoming earnings date is Nov 12, 2026, TBA (Confirmed).

Enzychem Lifesciences Corp. as a current ratio of 14.06, with Debt / Equity ratio of 3.52%

In the past 12 months, Enzychem Lifesciences Corp. has paid -147.22M in taxes.

Enzychem Lifesciences Corp. EV to EBITDA ratio is -8.49, with an EV/FCF ratio of -10.74.

Enzychem Lifesciences Corp. has ₩92.82B in cash and marketable securities with ₩4.84B in debt, giving a net cash position of ₩87.98B billion.

Gross margin is 4.99%, with operating margin of -19.32%, and net profit margin of -26.76%.

The average price target for Enzychem Lifesciences Corp. is ―, which is 11.43% higher than the current price. The consensus rating is ―